Article
Gene Therapy for Hemoglobinopathies
11 Sept 2018
Abstract excerpt
Gene therapy for β-thalassemia and sickle-cell disease is based on transplantation of genetically corrected, autologous hematopoietic stem cells. Preclinical and clinical studies have shown the safety and efficacy of this therapeutic approach, currently based on lentiviral vectors to transfer a β-globin gene under the transcriptional control of regulatory elements of the β-globin locus. Nevertheless, a number of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
